Global OTC Artificial Tears Market Growth Supplemented by Geriatric Population’s Susceptibility to Eye Diseases
Inkwood Research estimates that the Global OTC Artificial Tears Market is set to grow with a CAGR of 5.12% in terms of revenue during the forecasting years of 2021-2028.
“Browse 82 Market Data Tables and 58 Figures spread over 210
Pages, along with an in-depth TOC on the Global OTC Artificial Tears Market Forecast 2021-2028.”
REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/otc-artificial-tears-market/#request-free-sample
VIEW TABLE OF
CONTENT LINK - https://www.inkwoodresearch.com/reports/otc-artificial-tears-market/#table-of-contents
BUY NOW- https://www.inkwoodresearch.com/reports/otc-artificial-tears-market/
Artificial tears entail lubricant eye drops, used for the
treatment of irritation and dryness typically caused by the deficiency of tear
production. Artificial tears are formulated for initiating natural tears and treating
numerous eye disorders like allergy and infection, in addition to offering
protection from blue light and UV. It is also used for moisturizing contact
lenses.
Geriatric
Population’s Susceptibility to Eye Diseases to Fuel Market Growth
An increase in the geriatric population is set to fuel the
growth of the global OTC artificial tears market. The elderly are highly
susceptible to eye diseases like dry eye, age-related macular degeneration, glaucoma,
cataract, and presbyopia. Moreover, owing to the process of aging, the muscles
and the nerves surrounding the eyes become weak, and the lacrimal gland’s dysfunction
causes decreased tear production. In this regard, according to the data
published in the United Nations, in 2019, nearly 703 million people were
reported to be aged over 65. Globally, the percentage of the senior population
above the age of 65 years increased from 6% to 9% between 1990 to 2019. Besides,
the incidence of dry eye in the elderly is about 5% to 30%. Hence, the rise of the
geriatric population augments the growth of the global market.
To know more about this report, request a free sample copy.
Gel is the
Leading Product
A gel is a semisolid system formulated through the
interaction with colloidal particles as well as liquid vehicles. Ophthalmic
gels are available in a refreshing and silky texture, used to offer temporary
relief from the burning sensation and irritation of the eye. As a result, the
rising demand for eye gels, in addition to the increasing number of key
companies for manufacturing combinational semisolid ophthalmic drugs, are
anticipated to reinforce the market growth.
Asia-Pacific
to be the Fastest-Growing Region by 2028
The market in the Asia-Pacific is anticipated to register significant
growth over the forecast period owing to the rising number of cataract and
glaucoma surgeries, the growing geriatric population, and the elevated levels
of environmental pollution. Moreover, the increasing number of patients
diagnosed with dry eye disease and the high number of awareness programs for preventing
and managing ocular disease are set to provide lucrative opportunities for
manufacturers.
Sustainable competitive advantages by means of innovation are
predicted to enhance the competition among firms operating in the global
market. Therefore, powerful competitive strategies are anticipated to heighten
the industrial rivalry across the studied market.
Top players in the market are Sun Pharmaceutical Industries
Ltd, Bausch Health Companies Inc, Allergan PLC (Acquired by Abbvie), etc.
About Inkwood
Research
Inkwood Research specializes in syndicated & customized
research reports and consulting services. Market intelligence studies with
relevant fact-based research are customized across industry verticals such as
technology, automotive, chemicals, materials, healthcare, and energy, with an
objective comprehension that acknowledges the business environments. Our
geographical analysis comprises North & South America, CEE, CIS, Middle
East, Europe, Asia, and Africa.
Contact Us
https://www.inkwoodresearch.com
1-(857)293-0150
Related Reports:
GLOBAL OPHTHALMIC
LASERS MARKET
Comments
Post a Comment